"Bader brings a wealth of capital markets and M&A experience to NeOnc,” said Dr. Thomas Chen, Chief Executive Officer of NeOnc. “His extensive finance background will serve us well as we embark on our ...

“Dr. Medvec’s strategic value to our company is significant,” said Amir Heshmatpour, NeOnc’s Executive Chairman. “We anticipate receiving significant benefits from her insights and guidance as NeOnc ...